Failure of ditiocarb (diethyldithiocarbamate) therapy: Was diet the reason?

Current HIV Research

Volumn 7, Issue 3, 2009, Pages 254-

  Cvek, Boris ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FOOD; FOOD DRUG INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; ARTICLE; DIET; TREATMENT FAILURE;

ANTI-HIV AGENTS; DIET; DITIOCARB; HIV INFECTIONS; HUMANS; TREATMENT FAILURE;

EID: 67649101425     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788348038     Document Type: Review

References (13)

1. Lang JM, Touraine JL, Trepo C, et al. Randomized, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection. Lancet 1988; 332: 702-6.
2. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, Dietrich M. Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet 1990; 335: 679-82.
3. Hersh EM, Brewton G, Abrams D, et al. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA 1991; 265: 1538-44.
4. The HIV87 Study Group. Multicenter, randomized, placebocontrolled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients. AIDS Res Hum Retroviruses 1993; 9: 83-9.
5. Vanham GL, Kestens L, Van Hoof J, et al. Immunological parameters during treatment with ditiocarb (Imuthiol). AIDS 1993; 7: 525-30.
6. Cvek B, Dvorak Z. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? Drug Discov Today 2008; 13: 716-22.
7. Cvek B, Dvorak Z. Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals. Curr Pharm Des 2007; 13: 3155-67.
8. Cvek B, Milacic V, Taraba J, Dou QP. Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells. J Med Chem 2008; 51: 6256-8.
9. Piccinini M, Rinaudo MT, Chiapello N, et al. The human 26S proteasome is a target of antiretroviral agents. AIDS 2002; 16: 693-700.
10. Piccinini M, Rinaudo MT, Anselmino A, et al. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function. Antivir Ther 2005; 10: 215-23.
11. Lassot I, Latreille D, Rousset E, et al. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms. Mol Cell 2007; 25: 369-83.
12. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP. The status of disulfiram: a half of a century later. J Clin Psychofarmacol 2006; 26: 290-302.
13. Chong CR, Sullivan DJ. New uses for old drugs. Nature 2007; 448: 645-6.